Drug Trials Snapshots: BIMZELX

Summary

BIMZELX is an anti-interleukin (IL)-17A and IL-17F monoclonal antibody that is indicated for the treatment of adults with moderate to severe plaque psoriasis wh...

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Related coverage